Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma. | PLoS Comput Biol | 2021 | 34762643 | PubTator, text mining | PubMed |
| Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses. | J Ovarian Res | 2021 | 34758846 | PubTator, text mining | PubMed |
| Translational aspects of novel findings in genetics of male infertility-status quo 2021. | Br Med Bull | 2021 | 34755838 | PubTator, text mining | PubMed |
| RBM6 splicing factor promotes homologous recombination repair of double-strand breaks and modulates sensitivity to chemotherapeutic drugs. | Nucleic Acids Res | 2021 | 34718714 | PubTator, text mining | PubMed |
| Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy. | Medicina (Kaunas) | 2021 | 34684080 | PubTator, text mining | PubMed |
| Targeted Next-Generation Sequencing for the Identification of Genetic Predictors of Radiation-Induced Late Skin Toxicity in Breast Cancer Patients: A Preliminary Study. | J Pers Med | 2021 | 34683108 | PubTator, text mining | PubMed |
| Non-Recombinogenic Functions of Rad51, BRCA2, and Rad52 in DNA Damage Tolerance. | Genes (Basel) | 2021 | 34680945 | PubTator, text mining | PubMed |
| The Importance of Extended Analysis Using Current Molecular Genetic Methods Based on the Example of a Cohort of 228 Patients with Hereditary Breast and Ovarian Cancer Syndrome. | Genes (Basel) | 2021 | 34680878 | PubTator, text mining | PubMed |
| A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes. | Biomedicines | 2021 | 34680501 | PubTator, text mining | PubMed |
| Micronutrient imbalance and common phenotypes in neural tube defects. | Genesis | 2021 | 34665506 | PubTator, text mining | PubMed |
| DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation. | Front Genet | 2021 | 34659358 | PubTator, text mining | PubMed |
| Lamin A/C recruits ssDNA protective proteins RPA and RAD51 to stalled replication forks to maintain fork stability. | J Biol Chem | 2021 | 34648766 | PubTator, text mining | PubMed |
| XRCC2 Arg188His polymorphism and colorectal cancer risk: a meta-analysis. | J Int Med Res | 2021 | 34648414 | PubTator, text mining | PubMed |
| Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation. | Mol Biol Rep | 2021 | 34643925 | PubTator, text mining | PubMed |
| Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination. | NPJ Breast Cancer | 2021 | 34635660 | PubTator, text mining | PubMed |
| Genetic Susceptibility to Breast Cancer in Sub-Saharan African Populations. | JCO Glob Oncol | 2021 | 34623906 | PubTator, text mining | PubMed |
| Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair. | Life Sci Alliance | 2021 | 34610973 | PubTator, text mining | PubMed |
| XRCC3 loss leads to midgestational embryonic lethality in mice. | DNA Repair (Amst) | 2021 | 34601382 | PubTator, text mining | PubMed |
| Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial. | Clin Cancer Res | 2021 | 34593530 | PubTator, text mining | PubMed |
| A protein interaction landscape of breast cancer. | Science | 2021 | 34591612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=23